US Patent Issued to AstraZeneca on Sept. 9 for "Fused tricyclic compounds useful as anticancer agents" (British Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,187, issued on Sept. 9, was assigned to AstraZeneca AB (Sodertalje, Sweden).

"Fused tricyclic compounds useful as anticancer agents" was invented by Jason Grant Kettle (Cambridge, Great Britain), Iain Simpson (Cambridge, Great Britain), Christopher Phillips (Cambridge, Great Britain), Scott Boyd (Cambridge, Great Britain), Oliver Ross Steward (Cambridge, Great Britain), Michael Steven Bodnarchuk (Cambridge, Great Britain), Doyle Joseph Cassar (Cambridge, Great Britain) and Kurt Gordon Pike (Cambridge, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The specification relates to compounds of Formula (A) and pharmaceutically acceptable sa...